Drug Dissolution:Excipient vs Excipient

Slides:



Advertisements
Similar presentations
HA H + + A - B + H + BH + Acid Base Conjugate Base Conjugate Acid acid: donates protons (H + ) base: accepts protons (H + ) strong acid/base completely.
Advertisements

Ramana S. Uppoor, M.Pharm., Ph.D., R.Ph.
Pharmacology for Anesthesia I Introduction. What is a Drug?
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Topical Bioequivalence Update Robert Lionberger, Ph.D. Office of Generic Drugs.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Training Workshop on Pharmaceutical Development.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
Determine impurity level in relevant batches1
Office of New Drug Chemistry, OPS, CDER, Food and Drug Administration Establishing Dissolution Specification Current CMC Practice Vibhakar Shah, Ph.D.
VINOD P. SHAH, PH.D. SENIOR RESEARCH SCIENTIST OFFICE OF PHARMACEUTICAL SCIENCE CENTER FOR DRUG EVALUATION AND RESEARCH FOOD AND DRUG ADMINISTRATION Pharmacy.
1 Advisory Committee for Pharmaceutical Science May 3, 2005 Factors Impacting Drug Dissolution and Absorption : Current State of Science Lawrence X. Yu,
Solubility Product Constant Factors Affecting Solubility Selective Precipitation.
Ion-Exchange Resins as Drug Delivery Carriers Resins used are polymers that contain appropriately substituted acidic groups, such as carboxylic and sulfonic.
Tanzania, August, 2006 Dr. Barbara Sterzik, BfArM, Bonn 1 Guidelines and Tools available TRS 937 and BTIF (Bioequivalence Trial Information Form)
Quality By Design and Dissolution PhRMA 10/25/05
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Establishing Drug release/Dissolution Specifications – QBD Approach Moheb M. Nasr, Ph.D. Office of New Drug Quality Assessment (ONDQA), OPS, CDER Advisory.
Factors Affecting Drug Absorption (Pharmaceutical factor)
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
1-7.The ICH Q8 “Minimal Approach” to Pharmaceutical Development
Ionic equilibria Wan Rosalina Wan Rosli, PhD. Learning objectives At the end of this lecture, students should be able to: 1.Characterize electrolytes.
Novel Multifunctional Excipients by Co-processing with Mg-Silicate Dr. Faisal Al-Akayleh Faculty of Pharmacy, Petra University.
October 22, EFFECT OF PHYSICO- CHEMICAL PROPERTIES OF DRUG ON ABSORPTION By Dr. A. S. Adebayo.
Formulation factors By Dr. A. S. Adebayo.
Bioavailability Dr Mohammad Issa.
Microemulsion- A suitable Galenical approach for the absorption enhancement of low soluble compounds B.T. Gattefosse No. 88, p , 1995 A new microemulsion.
What Impact should ICH Q8 have on ICH Q6A Decision Trees?
1 Controlled drug release Dr Mohammad Issa. 2 Frequency of dosing and therapeutic index  Therapeutic index (TI) is described as the ratio of the maximum.
1 Abu Alam Ph.D. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 23, 2008.
Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
WHO Prequalification Programme June 2007 Training Workshop on Dissolution, Pharmaceutical Product Interchangeability and Biopharmaceutical Classification.
Formulation, Characterization of Pellets of Duloxetine Hydrochloride by Extrusion and Spheronization Prof. V. R. Sinha University Institute of Pharmaceutical.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
The Biopharmaceutical Classification System (BCS)
Introduction What is a Biowaiver?
Chapter 6. pKa & Chapter 7. Solubility
Bioavailability of Dietary Supplements: Key Issues in Defining the Research Agenda Impact of Formulation on Bioavailability? Discussion Leader: Stephen.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy, University of Andalas.
Interchangeability and study design Drs. Jan Welink Training workshop: Assessment of Interchangeable Multisource Medicines, Kenya, August 2009.
Impurities in Drugs author: srikanth N
开发报批美国 FDA 的仿制药 与相关问题探讨 上海复星普适医药科技有限公司何平. 内容提要 开发仿制药的重要性和机遇 开发仿制药的重要性和机遇 开发仿制药的挑战 开发仿制药的挑战 申报仿制药的分类 申报仿制药的分类 仿制药研发团队 仿制药研发团队 仿制药的研发过程 仿制药的研发过程 QbD 在制剂开发中怎么体现.
Faculty of Pharmacy and Medical Sciences Al-Ahliyya Amman University
Physico-chemical Control of Dosage Forms
- Pharmaceutical Equivalence Study
The Biopharmaceutical Classification System (BCS)
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Introduction What is a Biowaiver?
Introduction of Biopharmaceutics & Pharmacokinetics
Figure 6.2 Solution pH as a function of concentration for an acidic salt.
Gastrointestinal Absorption: Role of the Dosage Form
FORMULATION AND IN VITRO EVALUATION OF ATORVASTATIN SOLID DISPERSION
Biopharmaceutics factors affecting Modified release products
Hashem Alsaab*, Rami M. alzhrani, Sai HS. Boddu
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Self emulsifying Drug Delivery System : Formulation
Biopharmaceutic Considerations in Drug Product Design
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Factors Affecting Drug Absorption (Dosage form factor)
Pharmaceutical Technology I
Scientific rationale for EU regulatory expectations concerning product composition in case of Class-I and Class-III medicinal products Dr Ridha BELAIBA.
Lab -7- Capsules.
The Biopharmaceutical Classification System (BCS)
Lab -7- Capsules.
PH and Solvent Effect on Drug Solubility
Biopharmaceutics 4th year
Formulation factors By Dr. A. S. Adebayo.
Tablets.
Fenofibrate USP (Micronized, control)
Presentation transcript:

Drug Dissolution:Excipient vs Excipient Dr A V Gothoskar Technical Advisor Anshul Life Sciences

Agenda Definition Understanding excipients Role of dissolution Super-disintegrants Capsule shells Case studies © A V GOTHOSKAR 2017`

Definition Any substance, other than the active drug or product, that has been appropriately evaluated for safety and is included in a drug delivery system to either of the drug delivery system during its manufacture, protect, support or enhance or assist in or enhance any other attribute of the overall of the drug delivery system during storage or use. aid the processing stability, bioavailability, patient acceptability, product identification safety and effectiveness © A V GOTHOSKAR 2017

Understanding Excipients Excipients enable API’s Major source of variability QbD Impacts CQA Source of impurity? Patient safety Speed to market © A V GOTHOSKAR 2017

Central Role of Dissolution Ref: Emmanuel Scheubel Early phase of development Late phase Market © A V GOTHOSKAR 2017

Factors affecting in-vitro dissolution Dr Donald Murphy, Astra Zeneca UK, IRR Conference, May 07, Budapest © A V GOTHOSKAR 2017

SSG CCS PPS xPVP Super-disintegrants © A V GOTHOSKAR 2017

Drug Excipient binding interaction Super-disintegrants Drug Excipient binding interaction Unintended physicochemical interaction of excipient with drug Ionic in nature Results in slow and/or incomplete drug release Can impact BA if complex is not disrupted by physiological salt concentrations Schematic of model for assessing the effect of drug-excipient binding interaction on oral absorption and plasma PK with Langmuir isotherm equation Narang et al, JPP; 2012(64), 553-565 © A V GOTHOSKAR 2017

Super-disintegrants: CCS & SSG Interaction of croscarmellose with arginine and escitalopram in solution Interaction of sodium starch glycollate Arginine Escitalopram CCS Arginine complex Escitalopram complex Larsen et al, DDIP,2012; 38(10):1195-1199 Fransen et al; JPP 2008, 60:1583-1589 © A V GOTHOSKAR 2017

Drug Dissolution: CCS vs xPVP Brivanib alaninate Hydrophobic (log P = 2.5), weakly basic (pKa = 6.9), amine drug, Dose = 400 mg 24 mg superdisintegrant Narang et al, JPP; 2012(64), 553-565 © A V GOTHOSKAR 2017

Cationic Drugs Dissolution Water pH 1.2; 0.1 M HCl Water Water soluble Water Cationic Drugs Dissolution Chlorpromazine HCl Effect of Super-disintegrant on T80% Time Ranitidine HCl Cetirizine HCl Venlafaxine HCl pH 1.2; 0.1 M HCl pH 3; Citrate pH 1.2; 0.001 M HCl pH 2; HCl Poorly Water soluble CCS SSG xPVP Ciprofloxacin HCl Fexofenadin HCl Clopidogrel bisulfate Terbinafin HCl Balasubramanium et al, Disso Tech, May 2008; 18-25 © A V GOTHOSKAR 2017

HPMC Capsules Substitution Type Methoxy % Hydroxypropoxy % Anycoat grade 2208 19.0-24.0 4.0-12.0 C 2906 27.0-30.0 4.0-7.5 B 2910 28.0-30.0 7.0-12.0 A Inert Low moisture content Low water vapour permeability Less brittle even at low humidity High tolerance to temperature (800C vs 600C) No cross linking upon storage Contains co-gelling agent and gel promoter ion © A V GOTHOSKAR 2017

Drug Release: HPMC vs Gelatin Capsules Paracetamol dissolution Drug Dev & Delivery, 2 (2), 2002 © A V GOTHOSKAR 2017

Drug release: HPMC capsules Effect of gelling agents % caffeine released Caspugel brochure © A V GOTHOSKAR 2017

Summary Excipients are ACTIVE! Excipients determine the drug release Right selection of excipients = successful formulation Understanding excipients is key to bio-behaviour. © A V GOTHOSKAR 2017

Thank you